Brain network discovery opens new path for Parkinson’s treatment
Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 million globally, is characterized by debilitating symptoms such as tremors, movement difficulties, sleep disturbances and cognitive impairments.
SCAN - the somato-cognitive action network
This work demonstrates that Parkinson's is a SCAN disorder, and the data strongly suggest that if you target the SCAN in a personalized, precise manner you can treat Parkinson's more successfully than was previously possible. Changing the activity within SCAN could slow or reverse the progression of the disease, not just treat the symptoms."
Nico U. Dosenbach, MD, PhD, co-author, the David M. & Tracy S. Holtzman Professor of Neurology at WashU Medicine